rs61754019

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP2BP4_Moderate

The NM_000552.5(VWF):​c.1922C>T​(p.Ala641Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,482,824 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00091 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 1 hom. )

Consequence

VWF
NM_000552.5 missense

Scores

1
5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:8O:1

Conservation

PhyloP100: -0.115

Publications

1 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PP2
Missense variant in the VWF gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 149 curated pathogenic missense variants (we use a threshold of 10). The gene has 28 curated benign missense variants. Gene score misZ: 0.98969 (below the threshold of 3.09). Trascript score misZ: 3.5064 (above the threshold of 3.09). GenCC associations: The gene is linked to hereditary von Willebrand disease, von Willebrand disease type 2B, von Willebrand disease 1, von Willebrand disease 2, von Willebrand disease type 2A, von Willebrand disease type 2M, von Willebrand disease 3, von Willebrand disease type 2N.
BP4
Computational evidence support a benign effect (MetaRNN=0.104133815).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.1922C>T p.Ala641Val missense_variant Exon 15 of 52 ENST00000261405.10 NP_000543.3
VWFXM_047429501.1 linkc.1922C>T p.Ala641Val missense_variant Exon 15 of 52 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.1922C>T p.Ala641Val missense_variant Exon 15 of 52 1 NM_000552.5 ENSP00000261405.5
VWFENST00000538635.5 linkn.420+53635C>T intron_variant Intron 5 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.000913
AC:
139
AN:
152200
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00185
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00102
AC:
86
AN:
84122
AF XY:
0.00100
show subpopulations
Gnomad AFR exome
AF:
0.00115
Gnomad AMR exome
AF:
0.000248
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00237
Gnomad OTH exome
AF:
0.000376
GnomAD4 exome
AF:
0.00146
AC:
1936
AN:
1330508
Hom.:
1
Cov.:
31
AF XY:
0.00141
AC XY:
925
AN XY:
654644
show subpopulations
African (AFR)
AF:
0.000111
AC:
3
AN:
27112
American (AMR)
AF:
0.000145
AC:
4
AN:
27596
Ashkenazi Jewish (ASJ)
AF:
0.0000449
AC:
1
AN:
22264
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32380
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70884
European-Finnish (FIN)
AF:
0.000153
AC:
5
AN:
32766
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4014
European-Non Finnish (NFE)
AF:
0.00173
AC:
1830
AN:
1057988
Other (OTH)
AF:
0.00168
AC:
93
AN:
55504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
112
224
336
448
560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000913
AC:
139
AN:
152316
Hom.:
0
Cov.:
31
AF XY:
0.000765
AC XY:
57
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41574
American (AMR)
AF:
0.000196
AC:
3
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00185
AC:
126
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00150
Hom.:
0
Bravo
AF:
0.000842
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00148
AC:
4
ESP6500EA
AF:
0.000750
AC:
4
ExAC
AF:
0.000257
AC:
10

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:8Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Other:1
Dec 11, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The VWF c.1922C>T (p.Ala641Val) variant has been reported in the published literature in individuals with Type 1 von Willebrand disease (vWD) (PMIDs: 18344424 (2008), 18230755 (2008), 16985174 (2007)). The frequency of this variant in the general population, 0.0024 (117/48744 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -

-
Academic Unit of Haematology, University of Sheffield
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Apr 23, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported as heterozygous in a patient with coagulation disease from the published literature; however this patient also harbored a variant in the F11 gene (PMID: 31064749); Reported in the heterozygous state in an individual with type 1 von Willebrand disease; however, this individual had normal multimers, and incomplete cosegregation of the A641V variant with von Willebrand disease in the family was reported (PMID: 16985174, 18230755); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27734074, 22995991, 19506353, 18344424, 18230755, 33556167, 16985174, 31064749) -

Jun 11, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:2
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 09, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: VWF c.1922C>T (p.Ala641Val) results in a non-conservative amino acid change located in the VWF/SSPO/Zonadhesin-like, cysteine-rich domain (IPR014853) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.001 in 84122 control chromosomes. c.1922C>T has been reported in the literature in individuals affected with Von Willebrand Disease (example, Downes_2019, Goodeve_2007, Sadler_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Von Willebrand Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31064749, 16985174, 33556167). ClinVar contains an entry for this variant (Variation ID: 100196). Based on the evidence outlined above, the variant was classified as uncertain significance. -

von Willebrand disease type 1;C1264040:von Willebrand disease type 2;C1264041:von Willebrand disease type 3 Uncertain:2
Feb 09, 2016
Division of Human Genetics, Children's Hospital of Philadelphia
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Aug 28, 2020
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Hereditary von Willebrand disease Pathogenic:1
Feb 01, 2019
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

Hemorrhage Uncertain:1
-
ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.47
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.77
T
M_CAP
Pathogenic
0.67
D
MetaRNN
Benign
0.10
T
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Benign
1.9
L
PhyloP100
-0.12
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-2.4
N
REVEL
Uncertain
0.59
Sift
Benign
0.053
T
Sift4G
Benign
0.084
T
Polyphen
0.97
D
Vest4
0.68
MVP
0.73
MPC
0.32
ClinPred
0.066
T
GERP RS
-5.9
Varity_R
0.079
gMVP
0.39
Mutation Taster
=93/7
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61754019; hg19: chr12-6166046; API